Aducanumab Biosimilar - Research Grade

Aducanumab Biosimilar - Research Grade, Human IgG1
SKU
ICH5008-1MG
Packaging Unit
1mg
Manufacturer
Ichorbio

Availability: loading...
Price is loading...
Target: Beta Amyloid

Specificity: Detects human Beta Amyloid. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Aducanumab.

Purification method: This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.

Background: RUO Aducanumab is a human monoclonal antibody that selectively targets aggregated amyloid beta. In a transgenic mouse model of Alzheimer’s disease, aducanumab is shown to enter the brain, bind parenchymal amyloid beta, and reduce soluble and insoluble amyloid beta in a dose-dependent manner.

Concentration: 5mg/ml

Formulation: Sterile, preservative-free, solution in PBS. BSA and Azide free.

Purity: >95% by SDS-PAGE

Endotoxin: ≤ 1.0 EU/mg as determined by the LAL method

Use: Products are for research use only. Not for use in diagnostic or therapeutic procedures.
More Information
SKU ICH5008-1MG
Manufacturer Ichorbio
Manufacturer SKU ICH5008-1MG
Package Unit 1mg
Quantity Unit STK
Reactivity Human
Clonality Monoclonal
Application Functional Assay
Isotype Human IgG1
Product information (PDF) Download
MSDS (PDF) Download